The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Dube Michael P since 2024.
This trader's CIK number is 2019493.
At the time of last reporting, Dube Michael P was the VP, Chief Accounting Officer of Intellia Therapeutics, Inc.. (stock ticker symbol NTLA).
Also see all insider trading activities at Intellia Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | NTLA | 0 | $0 | 3,875 | $41,614 | 0 | $0 |
| 2024 | NTLA | 0 | $0 | 2,012 | $38,248 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-07-02 | NTLA | Sale | 2,503 | 9.95 | 24,904 |
| 2025-01-03 | NTLA | Sale | 1,372 | 12.18 | 16,710 |
| 2024-10-02 | NTLA | Sale | 2,012 | 19.01 | 38,248 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Dube Michael P (VP, Chief Accounting Officer of Intellia Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.